The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)
Titel:
The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)
Auteur:
Wiggers, Henrik Køber, Lars Gislason, Gunnar Schou, Morten Poulsen, Mikael Kjær Vraa, Søren Nielsen, Olav Wendelbo Bruun, Niels Eske Nørrelund, Helene Hollingdal, Malene Barasa, Anders Bøttcher, Morten Dodt, Karen Hansen, Vibeke Brogaard Nielsen, Gitte Knudsen, Anne Sejr Lomholdt, Jens Mikkelsen, Kirsten Vilain Jonczy, Bartlomiej Brønnum-Schou, Jens Poenaru, Monica Petronela Abdulla, Jawdat Raymond, Ilan Mahboubi, Kiomars Sillesen, Karen Serup-Hansen, Kristine Madsen, Jette Sandberg Kristensen, Søren Lund Larsen, Anders Hostrup Bøtker, Hans Erik Torp-Petersen, Christian Eiskjær, Hans Møller, Jacob Hassager, Christian Steffensen, Flemming Hald Bibby, Bo Martin Refsgaard, Jens Høfsten, Dan Eik Mellemkjær, Søren Gustafsson, Finn